61 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Congress Grills Drugmakers: 5 Key Takeaways https://www.fool.com/investing/2019/02/26/congress-grills-drugmakers-5-key-takeaways.aspx?source=iedfolrf0000001 Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
Chardan bullish on MeiraGTx after JNJ investment; shares up 14% https://seekingalpha.com/news/3437840-chardan-bullish-meiragtx-jnj-investment-shares-14-percent?source=feed_news_all Feb 27, 2019 - Chardan Capital Markets reiterates its Buy rating on gene therapy developer MeiraGTx (MGTX +14.4%) with a more bullish price target of $40 (165% upside) (from $30) after it announced a stake by a grou
3 Stocks to Buy Ahead of the Next Market Crash https://www.fool.com/investing/2019/02/28/3-stocks-to-buy-ahead-of-the-next-market-crash.aspx?source=iedfolrf0000001 Feb 28, 2019 - These three titans of their respective industries should be able to weather nearly any market environment.
The 3 Oldest Members of Biotech's Billion-Burned Club https://www.fool.com/investing/2019/03/03/the-3-oldest-members-of-biotechs-billion-burned-cl.aspx?source=iedfolrf0000001 Mar 03, 2019 - These biopharmaceutical startups have been losing their investors' money for decades.
The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy http://www.zacks.com/stock/news/357595/the-zacks-analyst-blog-highlights-facebook-johnson-johnson-jpmorgan-sun-life-and-evergy?cid=CS-ZC-FT-357595 Mar 04, 2019 - The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy
Can Smart Beta & Factor ETFs Beat the Market? http://www.zacks.com/stock/news/357973/can-smart-beta-factor-etfs-beat-the-market?cid=CS-ZC-FT-357973 Mar 06, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Can Smart Beta & Factor ETFs Beat the Market? http://www.zacks.com/stock/news/358467/can-smart-beta-factor-etfs-beat-the-market?cid=CS-ZC-FT-358467 Mar 08, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Johnson & Johnson (JNJ) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript) https://seekingalpha.com/article/4248819-johnson-and-johnson-jnj-presents-barclays-global-healthcare-broker-conference-call-transcript?source=feed_sector_healthcare Mar 14, 2019 - Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference Call March 14, 2019, 10:15 ET Company Participants Lesley Fishman - IR Chris DelOrefice - VP, IR Catherine Owen - President, Immu
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others http://www.zacks.com/stock/news/359854/pharma-stock-roundup-regulatory-updates-from-mrk-pfe-jj-agn-others?cid=CS-ZC-FT-359854 Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Company News For Mar 15, 2019 http://www.zacks.com/stock/news/359794/company-news-for-mar-15-2019?cid=CS-ZC--359794 Mar 15, 2019 - Companies In The News Are: BA, DG, JNJ, WAGE

Pages: 1234567

Page 1>